These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30967134)

  • 1. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
    Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
    BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.
    Ivanova SA; Osmanova DZ; Freidin MB; Fedorenko OY; Boiko AS; Pozhidaev IV; Semke AV; Bokhan NA; Agarkov AA; Wilffert B; Loonen AJ
    World J Biol Psychiatry; 2017 Apr; 18(3):239-246. PubMed ID: 27654063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia.
    Fedorenko OY; Paderina DZ; Loonen AJM; Pozhidaev IV; Boiko AS; Kornetova EG; Bokhan NA; Wilffert B; Ivanova SA
    Hum Psychopharmacol; 2020 Jul; 35(4):e2737. PubMed ID: 32383805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
    Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
    Peuskens J; Pani L; Detraux J; De Hert M
    CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia.
    Geers LM; Pozhidaev IV; Ivanova SA; Freidin MB; Schmidt AF; Cohen D; Boiko AS; Paderina DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Kosterink JGW; Touw DJ; Loonen AJM
    Br J Clin Pharmacol; 2020 Sep; 86(9):1827-1835. PubMed ID: 32198935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A
    Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics].
    Tiguntsev VV; Gerasimova VI; Kornetova EG; Fedorenko OY; Kornetov AN; Goncharova AA; Poltavskaya EG; Boyko AS
    Mol Biol (Mosk); 2023; 57(1):47-55. PubMed ID: 36976738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis.
    Sobolevskaia PA; Churilov LP; Fedotkina TV; Stepochkina A; Dolina A; Gvozdetckii AN; Andreev BV; Shoenfeld Y
    Psychiatr Danub; 2021; 33(Suppl 4):1106-1112. PubMed ID: 35354176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Ivanova SA; Osmanova DZ; Boiko AS; Pozhidaev IV; Freidin MB; Fedorenko OY; Semke AV; Bokhan NA; Kornetova EG; Rakhmazova LD; Wilffert B; Loonen AJ
    Schizophr Res; 2017 Apr; 182():110-114. PubMed ID: 27776952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA; Ellingrod VL; Acion L; Miller DD; Moline J; Tansey MJ; Schlechte JA
    Pharmacogenet Genomics; 2009 May; 19(5):373-82. PubMed ID: 19339912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    Iwata Y; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Plitman E; Chung JK; Mar W; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Mamo DC; Graff-Guerrero A
    J Clin Psychiatry; 2016 Dec; 77(12):e1557-e1563. PubMed ID: 28086010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
    Tsuboi T; Bies RR; Suzuki T; Mamo DC; Pollock BG; Graff-Guerrero A; Mimura M; Uchida H
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():178-82. PubMed ID: 23727135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
    Yasui-Furukori N; Saito M; Tsuchimine S; Nakagami T; Sato Y; Sugawara N; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1491-5. PubMed ID: 18579277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.